just imagine..., page-36

So if the factory is at max capacity making 150mil pa. (whos to say the patch wont go up to 1750+?) that could be 175mil pa.

That with 10-15-20mil medical sales.

Late stages for hpv and hsv vaccines. Partnering deals?

Expanded cardiocel applications, which could be alot quicker to get hospitals using them, as the chd patch would help persuade them.

All that plus 150-200mil pa revenue and your calling max 800mil mcap?



And ofcourse this is still all potential, but im just saying theres no way you could say max 50c.

If they reach these potentials then 50c is long gone.

Most of us are happy to wait 10years meercat